Hydroxyurea,
Showing 26 - 50 of 441
Myelofibrosis, Polycythemia Vera Trial in United States (TGR-1202, ruxolitinib)
Active, not recruiting
- Myelofibrosis
- Polycythemia Vera
-
Phoenix, Arizona
- +4 more
Jun 20, 2022
HIV Trial (Indinavir sulfate, Ritonavir, Hydroxyurea)
Withdrawn
- HIV Infections
- Indinavir sulfate
- +4 more
- (no location specified)
Oct 28, 2021
Sickle Cell Anemia, Children, Only Trial in United States (Hydroxyurea SDM Toolkit, Clinician Pocket Guide)
Recruiting
- Sickle Cell Anemia
- Children, Only
- Hydroxyurea SDM Toolkit
- Clinician Pocket Guide
-
Oakland, California
- +10 more
Feb 9, 2022
Hydroxyurea Exposure Limiting Pregnancy and Follow-Up Lactation
Recruiting
- Sickle Cell Disease
- Sickle Cell Anemia
- Chart Review
- Survey
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Dec 8, 2021
HIV Trial (Tetanus Toxoid Vaccine, Hydroxyurea, Didanosine)
Withdrawn
- HIV Infections
- Tetanus Toxoid Vaccine
- +2 more
- (no location specified)
Oct 28, 2021
Sickle Cell Disease Trial in Memphis (hydroxyurea, azathioprine, alemtuzumab, thioptepa, low dose total body irradiation and
Recruiting
- Sickle Cell Disease
- hydroxyurea, azathioprine, alemtuzumab, thioptepa, low dose total body irradiation and sirolimus
- hydroxyurea, azathioprine, alemtuzumab, thiotepa, plerixafor, low dose total body irradiation, cyclophosphamide and sirolimus
-
Memphis, TennesseeSt. Jude Children's Research Hospital
May 5, 2022
Sickle Cell Disease Trial in United States (HABIT Intervention)
Completed
- Sickle Cell Disease
- HABIT Intervention
-
Bronx, New York
- +3 more
Mar 7, 2022
Identify and Describe Predictive Factors for Thromboembolic
Not yet recruiting
- Polycythemia Vera
- Hydroxyurea
- Ruxolitinib
- (no location specified)
Nov 2, 2022
Sickle Cell Disease, Renal Function Disorder Trial in Creteil (Siklos)
Completed
- Sickle Cell Disease
- Renal Function Disorder
-
Creteil, FranceCentre de Référence des Syndromes Drépanocytaires Majeurs, Hôpit
Sep 20, 2021
Sickle Cell Disease Trial in Atlanta (procedure, drug, other, radiation)
Recruiting
- Sickle Cell Disease
- Bone Marrow Transplant (BMT)
- +7 more
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta
Sep 13, 2022
Sickle Cell Disease Trial in Assiut (Hydroxycarbamide 500 Mg Oral Capsule+L-Carnitine, Hydroxycarbamide 500 Mg Oral Capsule,
Completed
- Sickle Cell Disease
- Hydroxycarbamide 500 Mg Oral Capsule+L-Carnitine
- +2 more
-
Assiut, EgyptSafaa A A Khaled
Oct 15, 2021
Sickle Cell Disease, Stroke Trial in Kaduna (Hydroxyurea)
Recruiting
- Sickle Cell Disease
- Stroke
-
Kaduna, NigeriaBarau Dikko Teaching Hospital/Kaduna State University
Jun 24, 2022
HPV-Negative Squamous Cell Carcinoma Trial in Chicago (Paclitaxel, Carboplatin, Cetuximab)
Not yet recruiting
- HPV-Negative Squamous Cell Carcinoma
- Paclitaxel
- +6 more
-
Chicago, IllinoisUniversity of Chicago Medicine Comprehensive Cancer Center
Aug 16, 2023
Sickle Cell Anemia Trial in Santo Domingo (Hydroxyurea, TCD examination)
Active, not recruiting
- Sickle Cell Anemia
- Hydroxyurea
- TCD examination
-
Santo Domingo, Dominican RepublicEncargada del Servicio de Hematología-Oncología Hospital Infanti
Jan 17, 2023
Sickle Cell Anemia, Beta Thalassemia Trial run by the NHLBI (radiation, drug, biological)
Recruiting
- Sickle Cell Anemia
- Beta Thalassemia
- TBI
- +6 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (haploidentical stem cell transplant,
Recruiting
- Sickle Cell Disease
- haploidentical stem cell transplant
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 18, 2022
Stroke Prevention in Young Adults With Sickle Cell Anemia
Active, not recruiting
- Sickle Cell Disease
- +5 more
- Hydroxyurea therapy per standard care
-
Nashville, Tennessee
- +1 more
Jul 13, 2022
Thalassemia Trial in Peshawar (Thalidomide and Hydroxyurea)
Completed
- Thalassemia
- Thalidomide and Hydroxyurea
-
Peshawar, Khyber Pakhtukhwa, PakistanBlood Diseases Clinic
Mar 10, 2022